Low-Dose Aspirin in Pregnancy: Indications, Timing, and Dosing
Low-dose aspirin (81–150 mg daily) should be initiated between 12–16 weeks of gestation in pregnant women with high-risk factors for preeclampsia and continued daily until delivery. 1
Who Should Take Aspirin During Pregnancy
High-Risk Factors (Any One Warrants Aspirin)
- History of preeclampsia in a prior pregnancy, especially if early-onset (<34 weeks) 1, 2
- Chronic hypertension 1
- Type 1 or type 2 diabetes 1
- Renal disease 1
- Autoimmune disease (systemic lupus erythematosus, antiphospholipid syndrome) 1
- Multifetal gestation (twins or higher-order multiples) 1
Moderate-Risk Factors (Two or More Warrant Aspirin)
- First pregnancy (nulliparity) 1
- Maternal age ≥35 years 1
- Body mass index (BMI) >30 kg/m² 1
- Family history of preeclampsia 1
- Low socioeconomic status 1
- Interpregnancy interval ≥10 years 1
Optimal Timing of Initiation
Start aspirin between 12–16 weeks of gestation for maximum benefit. 1, 2 The biological rationale is that defective placentation and inadequate spiral artery remodeling occur in the first trimester; aspirin initiated during this critical window improves uteroplacental blood flow and prevents the cascade leading to preeclampsia. 1
- Initiation before 16 weeks is more effective than later initiation 1
- Starting before 20 weeks significantly reduces preeclampsia risk (RR 0.76,95% CI 0.64–0.90) 3
- Initiation as early as 6–11 weeks is safe and does not increase maternal, fetal, or neonatal adverse events or congenital anomalies 4
Dosing Recommendations
Standard Dosing for Most High-Risk Women
81–100 mg daily is the standard dose recommended by ACOG and USPSTF for most high-risk pregnant women. 1, 2, 5
Higher Dosing for Specific Populations
100–150 mg daily should be used in the following groups, as standard 81 mg dosing has proven inadequate: 1
Chronic hypertension: Standard 81 mg aspirin does not reduce superimposed preeclampsia rates (34.3% without aspirin vs. 35.5% with aspirin, p=0.79), and severe preeclampsia features actually increased in the aspirin group (21.7% vs. 31.0%, p=0.03). 1 Consider 150–162 mg daily instead. 1
Type 1 or type 2 diabetes: The American Diabetes Association recommends 100–150 mg daily, as diabetes is an independent risk factor for preeclampsia. 1
BMI >40 kg/m²: Higher BMI reduces aspirin absorption and effectiveness due to increased platelet turnover; 100–150 mg daily is needed to achieve adequate platelet inhibition. 1
Multifetal gestation: Higher doses (100–150 mg) should be considered. 1
International Perspective on Dosing
Many international guidelines recommend 150 mg daily as the optimal dose, including the Royal College of Obstetricians and Gynaecologists, International Federation of Gynecology and Obstetrics (FIGO), and German guidelines. 1 Meta-analyses demonstrate that aspirin doses ≥100 mg initiated before 16 weeks are significantly more effective than lower doses (RR 0.33,95% CI 0.19–0.57, p<0.0001). 1
Duration of Therapy
Continue aspirin daily until delivery. 1 Do not stop at 36 weeks, as this removes protection during the highest-risk period for preeclampsia, and preeclampsia can develop for the first time in the early postpartum period. 1 The recommendation to continue through delivery is supported by multiple international guidelines and is not associated with increased bleeding risks. 1
Exception for Planned Cesarean with Neuraxial Anesthesia
If a cesarean section with spinal anesthesia is planned, discontinue aspirin 7–10 days before the scheduled procedure to allow adequate platelet recovery, and verify platelet count >75 × 10⁹/L immediately before spinal anesthesia. 6
Benefits of Aspirin Prophylaxis
In high-risk women, low-dose aspirin provides: 1, 2
- 24% reduction in preeclampsia risk
- 14% reduction in preterm birth
- 20% reduction in intrauterine growth restriction (IUGR)
- Increased mean birthweight by approximately 130 g 2
The number needed to treat to prevent one case of preeclampsia is 42 in women at increased risk. 2
Safety Profile
Low-dose aspirin (75–162 mg daily) does not increase risks of: 1, 2, 4
- Placental abruption
- Postpartum hemorrhage
- Fetal intracranial bleeding
- Perinatal mortality
- Congenital anomalies
This safety profile holds even when aspirin is initiated as early as 6 weeks of gestation and continued until delivery. 4
FDA Labeling Caveat
The FDA label warns against aspirin use "during the last 3 months of pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery." 7 This warning refers to high-dose aspirin (>100 mg), not the prophylactic low doses (75–162 mg) used for preeclampsia prevention. 1 The evidence clearly demonstrates that low-dose aspirin continued until delivery is safe and effective. 1
Special Populations
Antiphospholipid Syndrome (APS)
- Obstetric APS: Combine low-dose aspirin (81–100 mg daily) with prophylactic-dose low-molecular-weight heparin (LMWH) starting in the first trimester. 1
- Thrombotic APS: Use therapeutic-dose LMWH with low-dose aspirin throughout pregnancy. 1
- Continue anticoagulation for 6–12 weeks postpartum. 1
- Add hydroxychloroquine to improve pregnancy outcomes. 1
Systemic Lupus Erythematosus (SLE)
- Initiate low-dose aspirin in the first trimester and continue until delivery. 1
- Add hydroxychloroquine throughout pregnancy to reduce disease activity and preeclampsia risk. 1
- Test for antiphospholipid antibodies early in pregnancy to identify those requiring combined aspirin + LMWH therapy. 1
Recurrent Pregnancy Loss
Women with recurrent pregnancy loss benefit from aspirin prophylaxis, particularly when combined with other risk factors. 1
Common Pitfalls to Avoid
Do not use 81 mg in women with chronic hypertension, diabetes, or BMI >40—these populations require 100–150 mg daily. 1
Do not stop aspirin at 36 weeks "just to be safe"—this is not evidence-based and removes protection during a critical period. 1
Do not confuse low-dose aspirin (75–162 mg) with high-dose aspirin—the FDA warning about third-trimester use refers to high doses, not prophylactic doses. 1, 7
Do not delay initiation beyond 16 weeks if possible—earlier initiation is more effective. 1, 3
Do not use aspirin for low-risk pregnancies—in the absence of high-risk factors, current evidence does not support prophylactic aspirin for prevention of early pregnancy loss, fetal growth restriction, stillbirth, or preterm birth. 5